News Category:

BioAlabama News

UAH, HudsonAlpha team as part of national $31.5 million genetics effort

Dr. Eric Mendenhall says the new ENCODE research will enable scientists to further explore how cells work.

Research that will be done by The University of Alabama in Huntsville (UAH) and HudsonAlpha Institute for Biotechnology will provide a framework by which scientists can better understand ...

Small molecule inhibitor prevents or impedes tooth cavities in a preclinical model

Sadanandan Velu, left, and Hui Wu

University of Alabama at Birmingham researchers have created a small molecule that prevents or impedes tooth cavities in a preclinical model. The inhibitor blocks the function of a key virulence enzyme in an oral bacterium, a molecular sabotage that ...

HudsonAlpha associate company iCubate® earns FDA clearance for innovative bloodstream infection detection test

iCubate’s “ARM-PCR” technology, integrated platform and initial assay now available for United States Clinical Laboratories Huntsville, Ala. – iCubate®, Inc., an innovative molecular diagnostic device company located on the HudsonAlpha Institute for Biotechnology campus, announced today that it has earned U.S. Food and Drug Administration ...
news categories: ,

HudsonAlpha and UAB awarded $10 million for newborn whole genome sequencing project

Huntsville, Ala. — HudsonAlpha Institute for Biotechnology, a nonprofit genomics and genetics research institute in Huntsville, Ala., in collaboration with the University of Alabama at Birmingham (UAB) School of Medicine and the University of Mississippi Medical Center, has been awarded a four-year, $10 million grant from the ...

UAH acquires DXA system for joint, bone and tissue research

While training to become a professional mountain bike racer, researcher Dr. Shannon Mathis discovered cyclists spend numerous hours exercising each week — yet most have low bone density. Since then, The University of Alabama in Huntsville (UAH) kinesiology professor has been consumed with learning more about bone ...
news categories: ,

HudsonAlpha Opens Hope Grows Garden: Breast and Ovarian Cancer

Huntsville, Ala. — HudsonAlpha Institute for Biotechnology held a grand opening for the “Hope Grows Garden: Breast and Ovarian Cancer,” to recognize its commitment to breast and ovarian cancer research and pay tribute to those people impacted by these devastating diseases. The ...
news categories: ,

A novel anti-cancer chemotherapeutic agent inhibits glioblastoma growth and radiation resistance

Ichiro Nakano, M.D., Ph.D.

Glioblastoma is a primary brain tumor with dismal survival rates, even after treatment with surgery, chemotherapy and radiation. A small subpopulation of tumor cells — glioma stem cells — is responsible for glioblastoma’s tumorigenesis, treatment resistance and subsequent tumor recurrence. A collaborative ...
news categories: , ,

Micron-sized hydrogel cubes show highly efficient delivery of a potent anti-cancer drug

Many potent anti-cancer drugs have major drawbacks — they fail to mix with water, which means they will have a limited solubility in blood, and they lack selectivity to cancer cells. Researchers at the University of Alabama at Birmingham and Texas Tech University Health Sciences ...

Auburn to host Alabama Launchpad Startup Competition

Local entrepreneurs who have a great product or service to share with the public are in luck: Alabama Launchpad has chosen Auburn as the home of its second regional competition for startups.
The competition, slated to begin this fall, is a result of a partnership among ...

Auburn University home to new pharmaceutical building

U.S. News and World Report ranks The Harrison School of Pharmacy at Auburn University as one of the top 25 pharmacy schools in the country, and their new pharmaceutical building matches their ranking. The 37,000 square foot building took 16 months and $16.6 million to complete, but it is expected ...